1558085

Source:http://linkedlifedata.com/resource/pubmed/id/1558085

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032143, umls-concept:C0151699, umls-concept:C0810126
pubmed:issue	4
pubmed:dateCreated	1992-5-1
pubmed:abstractText	We analyzed the clinical, laboratory, and radiologic data in nine patients who sustained an intracranial hemorrhage (ICH) after receiving intravenous recombinant tissue plasminogen activator (rt-PA) and heparin for treatment of acute myocardial infarction (MI). Our purpose was to delineate the clinical and radiologic features of the ICHs, as well as to determine their potential risk factors and mechanisms.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0267200
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Fibrinogen Degradation..., http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/duteplase
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0002-9343
pubmed:author	pubmed-author:BuckleyJ WJW, pubmed-author:FurlanA JAJ, pubmed-author:KassC ECE, pubmed-author:LittleJohnJ KJK, pubmed-author:PessinM SMS, pubmed-author:SnipesR GRG, pubmed-author:ZivinJ AJA, pubmed-author:del ZoppoG JGJ
pubmed:issnType	Print
pubmed:volume	92
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	384-90
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:1558085-Aged, pubmed-meshheading:1558085-Cerebral Hemorrhage, pubmed-meshheading:1558085-Cohort Studies, pubmed-meshheading:1558085-Female, pubmed-meshheading:1558085-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:1558085-Hematoma, Subdural, pubmed-meshheading:1558085-Heparin, pubmed-meshheading:1558085-Humans, pubmed-meshheading:1558085-Hypertension, pubmed-meshheading:1558085-Male, pubmed-meshheading:1558085-Middle Aged, pubmed-meshheading:1558085-Myocardial Infarction, pubmed-meshheading:1558085-Partial Thromboplastin Time, pubmed-meshheading:1558085-Platelet Aggregation Inhibitors, pubmed-meshheading:1558085-Recombinant Proteins, pubmed-meshheading:1558085-Risk Factors, pubmed-meshheading:1558085-Survival Rate, pubmed-meshheading:1558085-Thrombolytic Therapy, pubmed-meshheading:1558085-Tissue Plasminogen Activator
pubmed:year	1992
pubmed:articleTitle	Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
pubmed:affiliation	Department of Neurology, Boston University School of Medicine, Massachusetts 02118.
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study